Here are relevant reports on : age-verification-market
-
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028
The global continuous renal replacement therapy market, valued at US$1.3 billion in 2022, stood at US$1.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and rising incidences of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to accelerate the growth of the market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Europe Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer) - Forecast to 2030
The Europe telehealth & telemedicine market, valued at US$22.01 billion in 2024, stood at US$24.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$42.04 billion by the end of the period. The growth of the Europe telehealth & telemedicine market is driven by the rising demand for remote healthcare services, increasing adoption of digital health platforms, and expanding broadband and mobile connectivity across the region.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Nailing Systems Market by Product (Femoral Intramedullary Nails, Tibial Intramedullary Nail), Indication (Tibial fracture, humeral fracture), Material , Age Group, End User (Hospitals & Ambulatory Surgical Centers) & Region - Global Forecast to 2029
The global nailing systems market, valued at US$407.7 million in 2023, stood at US$427.7 million in 2024 and is projected to advance at a resilient CAGR of 5.3% from 2024 to 2029, culminating in a forecasted valuation of US$553.2 million by the end of the period. Market growth can be attributed to factors such as the rising prevalence of orthopedic disorders, the rising number of sports injuries, and increasing research funding and awareness initiatives.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Enteral Feeding Devices Market, by Type (Administration sets, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Respiratory), End User - Forecast to 2032
The Asia Pacific enteral feeding device market, valued at USD 0.76 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2032, culminating in a forecasted valuation of USD 1.20 billion by the end of the period. In the Asia Pacific enteral feeding devices market, the growth of enteral feeding tubes is primarily attributed to the incidence of diseases such as cancer, stroke, neurological disorders, and gastrointestinal diseases that often lead to swallowing difficulties and require prolonged nutrition support.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Europe Enteral Feeding Devices Market by Type [Tubes(Nasal, Gastrostomy), Pumps {Portable, Stationary}, Enteral Syringe, Administration Set, Consumable], Insertion Method, Age Group (Neonate, Pediatric, Geriatric), Application, End user- Forecast to 2032
The Europe enteral feeding device market, valued at USD 0.85 billion in 2025, stood at USD 0.88 billion in 2026 and is projected to advance at a resilient CAGR of 4.0% from 2026 to 2032, culminating in a forecasted valuation of USD 1.11 billion by the end of the period.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2030
The global sleep apnea oral appliances market, valued at US$0.4B in 2024, is forecasted to grow at a 9.8% CAGR, reaching US$0.5B by 2025 and US$0.8B by 2030.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Enteral Feeding Devices Market by Type (Nasogastric Tubes, Administration Sets, Nasal Feeding, Nasoduodenal, Syringes, Connectors), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The US enteral feeding device market, valued at US$1.13 billion in 2025, stood at US$1.19 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2032, culminating in a forecasted valuation of US$1.70 billion by the end of the period.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
The global age-related macular degeneration (AMD) drugs market, valued at US$9.55 billion in 2023, stood at US$10.46 billion in 2024 and is projected to advance at a resilient CAGR of 10.7% from 2024 to 2029, culminating in a forecasted valuation of US$17.37 billion by the end of the period. Factors such as the increase in the prevalence of AMD cases due to the changing lifestyle and dietary habits such as smoking, alcohol consumption, and lack of physical activity, a growing focus on research and development highlighted by steady development and approvals of AMD drugs along with improvements in reimbursement policies providing better and affordable access to therapeutic AMD drugs, supports the growth of this market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
